TY - JOUR
T1 - Clinical presentation, management, and outcomes of angiographically documented early, late, and very late stent thrombosis
AU - Armstrong, Ehrin J.
AU - Feldman, Dmitriy N.
AU - Wang, Tracy Y.
AU - Kaltenbach, Lisa A.
AU - Yeo, Khung Keong
AU - Wong, S. Chiu
AU - Spertus, John
AU - Shaw, Richard E.
AU - Minutello, Robert M.
AU - Moussa, Issam
AU - Ho, Kalon K.L.
AU - Rogers, Jason H.
AU - Shunk, Kendrick A.
N1 - Funding Information:
This research was supported by the American College of Cardiology Foundation's NCDR (National Cardiovascular Data Registry). The views expressed in this manuscript represent those of the author(s), and do not necessarily represent the official views of the NCDR or its associated professional societies identified at the NCDR website. CathPCI Registry is an initiative of the American College of Cardiology Foundation and the Society for Cardiovascular Angiography and Interventions. Dr. Feldman has received consulting fees from Maquet, Gilead Sciences, and is on the Speaker's Bureau for Eli Lilly, Daiichi Sankyo, Abbott Vascular, and The Medicines Company. Dr. Wang has received consulting fees from Medco and AstraZeneca; grant support from BMS-Sanofi , Schering-Plough/Merck , Eli Lilly , Daiichi Sankyo , Canyon Pharmaceuticals , Heartscape , Medco , AstraZeneca , and The Medicines Company ; and payment for lectures and educational conferences from the American College of Cardiology Foundation. Ms. Kaltenbach is an employee of the Duke Clinical Research Institute, which receives funding support from the American College of Cardiology-NCDR. Dr. Spertus has a contract with the American College of Cardiology Foundation to serve as an Analytic Center for the NCDR. Dr. Minutello is on the Speaker's Bureau for Merck and Possis. Dr. Rogers has received consulting fees from Volcano, Medtronic, Cordis, and Boston Scientific. Dr. Shunk has received institutional research support from Siemens Medical Systems, Abbott Vascular, and InfraRedx. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
PY - 2012/2
Y1 - 2012/2
N2 - Objectives: The aim of this study was to describe differences in treatment and in-hospital mortality of early, late, and very late stent thrombosis (ST). Background: Early, late, and very late ST may differ in clinical presentation, management, and in-hospital outcomes. Methods: We analyzed definite (angiographically documented) ST cases identified from February 2009 to June 2010 in the CathPCI Registry. We stratified events by timing of presentation: early (≤1 month), late (1 to 12 months), or very late (<12 months) following stent implantation. Multivariable logistic regression modeling was performed to compare in-hospital mortality for each type of ST after adjusting for baseline comorbidities. Results: During the study period, 7,315 ST events were identified in 7,079 of 401,662 patients (1.8%) presenting with acute coronary syndromes. This ST cohort consisted of 1,391 patients with early ST (19.6%), 1,370 with late ST (19.4%), and 4,318 with very late ST (61.0%). Subjects with early ST had a higher prevalence of black race and diabetes, whereas subjects with very late ST had a higher prevalence of white race and a lower prevalence of prior myocardial infarction or diabetes. In-hospital mortality was significantly higher in early ST (7.9%) compared with late (3.8%) and very late ST (3.6%, p < 0.001). This lower mortality for late and very late ST persisted after multivariable adjustment (odds ratio: 0.53 [95% confidence interval (CI): 0.36 to 0.79] and 0.58 [95% CI: 0.43 to 0.79], respectively). Conclusions: Significant differences exist in the presentation and outcomes of early, late, and very late ST. Among patients with acute coronary syndromes who are undergoing percutaneous coronary intervention for angiographically documented ST, early ST is associated with the highest in-hospital mortality.
AB - Objectives: The aim of this study was to describe differences in treatment and in-hospital mortality of early, late, and very late stent thrombosis (ST). Background: Early, late, and very late ST may differ in clinical presentation, management, and in-hospital outcomes. Methods: We analyzed definite (angiographically documented) ST cases identified from February 2009 to June 2010 in the CathPCI Registry. We stratified events by timing of presentation: early (≤1 month), late (1 to 12 months), or very late (<12 months) following stent implantation. Multivariable logistic regression modeling was performed to compare in-hospital mortality for each type of ST after adjusting for baseline comorbidities. Results: During the study period, 7,315 ST events were identified in 7,079 of 401,662 patients (1.8%) presenting with acute coronary syndromes. This ST cohort consisted of 1,391 patients with early ST (19.6%), 1,370 with late ST (19.4%), and 4,318 with very late ST (61.0%). Subjects with early ST had a higher prevalence of black race and diabetes, whereas subjects with very late ST had a higher prevalence of white race and a lower prevalence of prior myocardial infarction or diabetes. In-hospital mortality was significantly higher in early ST (7.9%) compared with late (3.8%) and very late ST (3.6%, p < 0.001). This lower mortality for late and very late ST persisted after multivariable adjustment (odds ratio: 0.53 [95% confidence interval (CI): 0.36 to 0.79] and 0.58 [95% CI: 0.43 to 0.79], respectively). Conclusions: Significant differences exist in the presentation and outcomes of early, late, and very late ST. Among patients with acute coronary syndromes who are undergoing percutaneous coronary intervention for angiographically documented ST, early ST is associated with the highest in-hospital mortality.
KW - acute coronary syndrome(s)
KW - cardiovascular outcomes
KW - stent thrombosis
UR - http://www.scopus.com/inward/record.url?scp=84863115523&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84863115523&partnerID=8YFLogxK
U2 - 10.1016/j.jcin.2011.10.013
DO - 10.1016/j.jcin.2011.10.013
M3 - Article
C2 - 22361596
AN - SCOPUS:84863115523
SN - 1936-8798
VL - 5
SP - 131
EP - 140
JO - JACC: Cardiovascular Interventions
JF - JACC: Cardiovascular Interventions
IS - 2
ER -